RecruitingNot ApplicableNCT06426524
Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph Study
Sponsor
Dr R Viswa Chandra
Enrollment
24 participants
Start Date
May 19, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to clinically evaluate the efficacy of Insulin like Growth Factor (IGF-1) on bone regeneration in intrabony defects.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Systemically healthy male and female patients of age \>18 years Intrabony defects - two wall or three wall defects Probing pocket depths (PPD) of \>5mm.
Exclusion Criteria1
- Medically compromised patients Pregnant women Heavy smokers Patients who underwent radiotherapy or chemotherapy are excluded
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREIGF-1 Gel
After degranulation of the defect, IGF-1 gel mixed with Hydroxyapatite graft will be placed in the defect.
PROCEDUREHydroxyapatite
After degranulation of the defect, Hydroxyapatite graft will be placed in the defect.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06426524
Related Trials
Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts
NCT071467761 location
Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects
NCT060480421 location
Rh-PDGF vs EMD for Treatment of Intra-bony Defects
NCT054420341 location